Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2373-8057
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease ; volume:8 ; number:1 ; day:5 ; month:8 ; year:2022 ; pages:1-7 ; date:12.2022
npj Parkinson's Disease ; 8, Heft 1 (5.8.2022), 1-7, 12.2022

Creator
Tezuka, Toshiki
Taniguchi, Daisuke
Sano, Mariko
Shimada, Tomoyo
Oji, Yutaka
Tsunemi, Taiji
Ikeda, Aya
Li, Yuanzhe
Yoshino, Hiroyo
Ogata, Jun
Shiba-Fukushima, Kahori
Funayama, Manabu
Nishioka, Kenya
Imai, Yuzuru
Hattori, Nobutaka
Contributor
SpringerLink (Online service)

DOI
10.1038/s41531-022-00367-y
URN
urn:nbn:de:101:1-2022102019210707744907
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Tezuka, Toshiki
  • Taniguchi, Daisuke
  • Sano, Mariko
  • Shimada, Tomoyo
  • Oji, Yutaka
  • Tsunemi, Taiji
  • Ikeda, Aya
  • Li, Yuanzhe
  • Yoshino, Hiroyo
  • Ogata, Jun
  • Shiba-Fukushima, Kahori
  • Funayama, Manabu
  • Nishioka, Kenya
  • Imai, Yuzuru
  • Hattori, Nobutaka
  • SpringerLink (Online service)

Other Objects (12)

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions

Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions

The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease

The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition

LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease

LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease

Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules

Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease

Hochschulschrift

Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease

Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models

Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease

Related objects